brizo

Brizo is a unique **dietary supplement** designed to support prostate health in men, specifically formulated to alleviate lower urinary tract symptoms such as urinary frequency, urgency, and nocturia associated with prostate enlargement. The active ingredient, SC012, is a proprietary botanical compound derived from the soybean plant via a unique process. SC012 acts as a selective modulator of estrogen receptors—exhibiting agonist activity on estrogen receptor beta (ERβ) and antagonist activity on estrogen receptor alpha (ERα)—and additionally antagonizes the androgen receptor, thereby modulating prostatic growth pathways without producing the undesirable systemic effects typically seen with hormonal therapies. Brizo is marketed and manufactured by Se-cure Pharmaceuticals and is taken orally as a capsule. It is positioned as a non-pharmaceutical nutraceutical or advanced botanical supplement for long-term management of benign prostatic symptoms, aiming for efficacy without conventional side effects.

Brand names

Brizo

Other names

brizoSC012SC-012SC 012